A total of 14 products were added during the month, from eight different asset managers: Deerpath Capital, Echiquier, Eurizon, Franklin Templeton, Invesco, JP Morgan, Reverence Capital Partners. and UBAM.
CCR Monthly Approval Report – June 2026
In June, Allianz, BlackRock, Bluebay, Fidelity, First Trust, GAM, I Squared Capital, Morgan Stanley and Xtrackers were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – May 2026
A total of 11 products were added in the month from five different asset managers: Artemis, Columbia, Five Arrows, L Catterton and Xtrackers.
CCR Monthly Approval Report – April 2026
A total of six products were added in the month from six different asset managers: Aegon, Blackstone, DWS, Patria, Spruceview and Vontobel.
CCR Monthly Approval Report – March 2026
A total of seven products were added in the month from: Allianz, AltamarCAM Partners, Franklin Templeton, LS Power Equity Advisors, PIMCO and Vanguard.
CCR Monthly Approval Report – February 2026
A total of 19 products were added in the month from 12 different asset managers: ACRE Advisors, Amundi, Archimed, Bice, BlackRock, Eastspring, Invesco, iShares, MGG Investment Group, Stellex Capital, Stone Harbor and VanEck.
Chile’s FAPP Investment framework delays alternatives allocation
New rules impose a 24-month ban on private markets, cap equities at 60%, and set a 50–80% international allocation range.
ETF listings approved by the CCR reach 875 products
Asset managers are expanding their ETF footprint in anticipation of asset allocation shifts driven by Chile’s pension reform, positioning themselves for the transition to a generational fund structure.
CCR Monthly Approval Report – January 2026
Sponsors gaining approval were Amundi, Azimut, Blue Owl Capital, Echiquier, Eurazeo, Invesco, iShares, Leonard Green and M&G.
CCR Monthly Approval Report – December 2025
Bradesco, HSBC, Invesco, VanEck, Wisdomtree, Lone Star Funds and TPG Angelo Gordon were the fund sponsors gaining approval for new product.



